Clinical characteristics and prognosis of hepatocellular carcinoma with different sets of serum AFP and PIVKA-II levels

Se Hun Kang, doyoung kim, Soung Min Jeon, SangHoon Ahn, Junyong Park, Seungup Kim, Ja Kyung Kim, Kwan Sik Lee, Chae Yoon Chon, KwangHyub Han

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

OBJECTIVE: α-Fetoprotein (AFP) and prothrombin induced by the absence of vitamin K or antagonist-II (PIVKA-II) are useful tumor markers for hepatocellular carcinoma (HCC). However, little is known about the clinical characteristics and prognosis of HCC with different levels of AFP and PIVKA-II. Methods: Consecutive 1447 HCC patients were assigned to four groups according to the cutoff values of AFP (400 ng/ml) and PIVKA-II (100 mAU/ml): both values high (AP), one of the values high (Ap and aP), and both values low (ap). The clinical characteristics and the prognosis of group ap were compared with those of the other groups. Results: HCC patients in group ap were more asymptomatic at diagnosis, and had smaller size, fewer numbers, and earlier stages of HCC, and more preserved liver functions (all, P<0.001). The survival rate of group ap was significantly higher than those of the other groups (P<0.001). In multivariate analysis, the combined status of AFP and PIVKA-II values were independent predictors for survival (P<0.001), together with tumor size, number, portal vein thrombosis, Child-Pugh class, and treatment modality. Conclusion: HCC patients with low values of both AFP and PIVKA-II had more favorable clinical characteristics and showed a better prognosis than those with elevated levels of AFP or PIVKA-II.

Original languageEnglish
Pages (from-to)849-856
Number of pages8
JournalEuropean Journal of Gastroenterology and Hepatology
Volume24
Issue number7
DOIs
Publication statusPublished - 2012 Jul 1

Fingerprint

Vitamin K
Prothrombin
Hepatocellular Carcinoma
Serum
Fetal Proteins
Tumor Biomarkers
Portal Vein
Thrombosis
Multivariate Analysis
Survival Rate
Survival
Liver
Neoplasms

All Science Journal Classification (ASJC) codes

  • Hepatology
  • Gastroenterology

Cite this

@article{92d01df7d658468f88d37d8b7c6bd02a,
title = "Clinical characteristics and prognosis of hepatocellular carcinoma with different sets of serum AFP and PIVKA-II levels",
abstract = "OBJECTIVE: α-Fetoprotein (AFP) and prothrombin induced by the absence of vitamin K or antagonist-II (PIVKA-II) are useful tumor markers for hepatocellular carcinoma (HCC). However, little is known about the clinical characteristics and prognosis of HCC with different levels of AFP and PIVKA-II. Methods: Consecutive 1447 HCC patients were assigned to four groups according to the cutoff values of AFP (400 ng/ml) and PIVKA-II (100 mAU/ml): both values high (AP), one of the values high (Ap and aP), and both values low (ap). The clinical characteristics and the prognosis of group ap were compared with those of the other groups. Results: HCC patients in group ap were more asymptomatic at diagnosis, and had smaller size, fewer numbers, and earlier stages of HCC, and more preserved liver functions (all, P<0.001). The survival rate of group ap was significantly higher than those of the other groups (P<0.001). In multivariate analysis, the combined status of AFP and PIVKA-II values were independent predictors for survival (P<0.001), together with tumor size, number, portal vein thrombosis, Child-Pugh class, and treatment modality. Conclusion: HCC patients with low values of both AFP and PIVKA-II had more favorable clinical characteristics and showed a better prognosis than those with elevated levels of AFP or PIVKA-II.",
author = "Kang, {Se Hun} and doyoung kim and Jeon, {Soung Min} and SangHoon Ahn and Junyong Park and Seungup Kim and Kim, {Ja Kyung} and Lee, {Kwan Sik} and Chon, {Chae Yoon} and KwangHyub Han",
year = "2012",
month = "7",
day = "1",
doi = "10.1097/MEG.0b013e3283535c34",
language = "English",
volume = "24",
pages = "849--856",
journal = "European Journal of Gastroenterology and Hepatology",
issn = "0954-691X",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

Clinical characteristics and prognosis of hepatocellular carcinoma with different sets of serum AFP and PIVKA-II levels. / Kang, Se Hun; kim, doyoung; Jeon, Soung Min; Ahn, SangHoon; Park, Junyong; Kim, Seungup; Kim, Ja Kyung; Lee, Kwan Sik; Chon, Chae Yoon; Han, KwangHyub.

In: European Journal of Gastroenterology and Hepatology, Vol. 24, No. 7, 01.07.2012, p. 849-856.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Clinical characteristics and prognosis of hepatocellular carcinoma with different sets of serum AFP and PIVKA-II levels

AU - Kang, Se Hun

AU - kim, doyoung

AU - Jeon, Soung Min

AU - Ahn, SangHoon

AU - Park, Junyong

AU - Kim, Seungup

AU - Kim, Ja Kyung

AU - Lee, Kwan Sik

AU - Chon, Chae Yoon

AU - Han, KwangHyub

PY - 2012/7/1

Y1 - 2012/7/1

N2 - OBJECTIVE: α-Fetoprotein (AFP) and prothrombin induced by the absence of vitamin K or antagonist-II (PIVKA-II) are useful tumor markers for hepatocellular carcinoma (HCC). However, little is known about the clinical characteristics and prognosis of HCC with different levels of AFP and PIVKA-II. Methods: Consecutive 1447 HCC patients were assigned to four groups according to the cutoff values of AFP (400 ng/ml) and PIVKA-II (100 mAU/ml): both values high (AP), one of the values high (Ap and aP), and both values low (ap). The clinical characteristics and the prognosis of group ap were compared with those of the other groups. Results: HCC patients in group ap were more asymptomatic at diagnosis, and had smaller size, fewer numbers, and earlier stages of HCC, and more preserved liver functions (all, P<0.001). The survival rate of group ap was significantly higher than those of the other groups (P<0.001). In multivariate analysis, the combined status of AFP and PIVKA-II values were independent predictors for survival (P<0.001), together with tumor size, number, portal vein thrombosis, Child-Pugh class, and treatment modality. Conclusion: HCC patients with low values of both AFP and PIVKA-II had more favorable clinical characteristics and showed a better prognosis than those with elevated levels of AFP or PIVKA-II.

AB - OBJECTIVE: α-Fetoprotein (AFP) and prothrombin induced by the absence of vitamin K or antagonist-II (PIVKA-II) are useful tumor markers for hepatocellular carcinoma (HCC). However, little is known about the clinical characteristics and prognosis of HCC with different levels of AFP and PIVKA-II. Methods: Consecutive 1447 HCC patients were assigned to four groups according to the cutoff values of AFP (400 ng/ml) and PIVKA-II (100 mAU/ml): both values high (AP), one of the values high (Ap and aP), and both values low (ap). The clinical characteristics and the prognosis of group ap were compared with those of the other groups. Results: HCC patients in group ap were more asymptomatic at diagnosis, and had smaller size, fewer numbers, and earlier stages of HCC, and more preserved liver functions (all, P<0.001). The survival rate of group ap was significantly higher than those of the other groups (P<0.001). In multivariate analysis, the combined status of AFP and PIVKA-II values were independent predictors for survival (P<0.001), together with tumor size, number, portal vein thrombosis, Child-Pugh class, and treatment modality. Conclusion: HCC patients with low values of both AFP and PIVKA-II had more favorable clinical characteristics and showed a better prognosis than those with elevated levels of AFP or PIVKA-II.

UR - http://www.scopus.com/inward/record.url?scp=84862182834&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862182834&partnerID=8YFLogxK

U2 - 10.1097/MEG.0b013e3283535c34

DO - 10.1097/MEG.0b013e3283535c34

M3 - Article

C2 - 22495400

AN - SCOPUS:84862182834

VL - 24

SP - 849

EP - 856

JO - European Journal of Gastroenterology and Hepatology

JF - European Journal of Gastroenterology and Hepatology

SN - 0954-691X

IS - 7

ER -